Package 42794-014-08

Brand: ultramicrosize griseofulvin

Generic: ultramicrosize griseofulvin
NDC Package

Package Facts

Identity

Package NDC 42794-014-08
Digits Only 4279401408
Product NDC 42794-014
Product ID 42794-014_d58d8124-4925-b8a1-e053-2995a90ac4c5
Description

30 TABLET in 1 BOTTLE (42794-014-08)

Marketing

Marketing Status
Marketed Since 2016-05-11
Brand ultramicrosize griseofulvin
Generic ultramicrosize griseofulvin
Sample Package No

Linked Drug Pages (1)

Ultramicrosize Griseofulvin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d58d8124-4925-b8a1-e053-2995a90ac4c5", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0342794013089", "0342794014086"], "unii": ["32HRV3E3D5"], "rxcui": ["239239", "242831"], "spl_set_id": ["37b4d132-84f1-4394-b468-7e74eeec61eb"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (42794-014-08)", "package_ndc": "42794-014-08", "marketing_start_date": "20160511"}], "brand_name": "Ultramicrosize Griseofulvin", "product_id": "42794-014_d58d8124-4925-b8a1-e053-2995a90ac4c5", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "42794-014", "generic_name": "Ultramicrosize Griseofulvin", "labeler_name": "Sigmapharm Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ultramicrosize Griseofulvin", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "250 mg/1"}], "application_number": "ANDA202545", "marketing_category": "ANDA", "marketing_start_date": "20121115", "listing_expiration_date": "20261231"}